From NIH National Cancer Institute Web Sites
- Childhood Cancer Genomics (PDQ®) Health Professional Version
- Divide and Conquer: The Molecular Diagnosis of Cancer
- DNA Misfolding Revealed as Novel Oncogenic Mechanism
- FDA Approves Pembrolizumab for Tumors with Specific Genetic Features
NCI, June 20, 2017 - How Genomics Is Shaping Precision Medicine in Oncology
.png)
No hay comentarios:
Publicar un comentario